LI_182172
|
Pages: 124
|
Jan 2018 | 4047 Views
|
![]() ![]() |
|
Author's :
Sohail Shaikh & Onkar Sumant
|
Tables: 58
|
Charts: 24
|
Formats*:
![]() ![]() ![]() |
![]() ![]() |
The India IVF Services Market was valued at $256.0 million in 2016, and is estimated to reach $829.5 million by 2023, registering a CAGR of 18.2% from 2017-2023. The India IVF services market is developing steadily and is projected to grow at a high rate, owing to increase in awareness among the populace with respect to infertility and programs that are projected to develop patient confidence.
High success rates of conception associated with IVF also accelerates the market growth. Furthermore, high prevalence of infertility among population, change in lifestyle, growth in acceptance of ART and IVF, and increase in awareness about IVF among the non-metro regions have driven the adoption of IVF services in India. However, ethical and legal issues related to embryo transfer surrogacy major restrain the market. In addition, lack of established regulations with respect to IVF also impedes market growth. Likewise, high potential for improvement of healthcare service penetration in India presents lucrative opportunities for the overall development of the IVF market in India.
The India IVF services market is segmented based on gender, procedure, offering, cycle type, and end user. Based on gender, it is divided into female infertility, male infertility, and both (combined) infertility. Based on procedure, it is classified into intracytoplasmic sperm injection (ICSI-IVF), non-ICSI-IVF, and intrauterine insemination (IUI). The offering segment includes drugs, media & reagents, and services. Based on cycle type, the market is categorized into fresh cycle (non-donor), thawed cycle (non-donor), and donor egg IVF cycle. Based on end user, it is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes.
Fertility clinics occupied the largest share in the India IVF services market owing to the availability and accessibility of different services related to IVF such as infertility treatment, IVF programs, egg donation, intracytoplasmic sperm injection (ICSI), intra-cytoplasmic morphologically selected sperm injection (IMSI), and others in these clinics.
Thawed (non-donor) cycles is anticipated to be one of the most lucrative segments in the India IVF services market, owing to their wider applicability in IVF procedures. The prominent companies, hospitals, surgical centers, fertility centers, and clinical research institutes profiled in this report include Sun Pharmaceuticals Industries Ltd., Lab IVF Asia Pte. Ltd., LG Life Sciences, Cadila Pharmaceuticals Ltd., Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd., Southend Fertility and IVF Centre, Nova IVI Fertility, Bloom Fertility Center, Manipalankur Andrology and Reproductive Medicine, Cloudnine Hospitals, Gunasheela Hospital Mathrutva Fertility Centre (A Unit Of Max HealthCare Pvt. Ltd.) Milann, and Oasis Center (a unit of the entity Sadguru Healthcare Services Pvt. Ltd.). Other players (profiles not included in the report) in the value chain analysis include Apollo Hospitals, Fortis Hospitals, Ruby Hall IVF & Endoscopy Center., and others.
Key Benefits
In vitro fertilization (IVF) stands for fertilization of the male and female gametes that form the human embryo outside the womb-in a petri-dish in laboratory settings. This embryo is then transferred to the uterus for gestation. It is one of the most popular assisted reproductive technologies (ART) for successful fertilization. IVF treatment is preferred for women with missing or blocked fallopian tubes. In addition, structural causes that cause infertility such as fibroids, endometriosis, cervical problems, and polycystic ovary syndrome also require IVF intervention
The India IVF services market is anticipated to witness considerable growth in future owing to rise in incidence of infertility cases, emerging trend of delayed pregnancies among women, technological advancements in IVF procedures, and increased occurrences of gamete donations. Furthermore, low cost clinical settings for IVF treatments in India when compared with IVF treatment facilities in the U.S., the UK, and other established markets, surge in popularity of medical & fertility tourism coupled with advanced IVF facilities & treatment options are anticipated to supplement the market growth.
However, inadequate reimbursement policies associated with IVF treatment are anticipated to impede the market growth during the forecast period. Moreover, growth in interest of single parents as well as same sex couples in experiencing parenthood through artificial reproductive technology (ART), especially IVF, is expected to present lucrative opportunities for market expansion. At present, the fertility clinics are the largest end users of IVF treatment, followed by hospitals, surgical centers, and clinical research institutes.
* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.
Enterprice
License/PDF
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high level data integrity, accurate analysis and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.